Bioavailability of Clindamycin From a New Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3% Combination Gel-Reference-Cited by-同舟云学术

Bioavailability of Clindamycin From a New Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3% Combination Gel

Published:2013-01 Issue:1 Volume:2 Page:33-47
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:CPDD

Author:

Jones Terry M.¹,Jasper Stacy²,Alió Sáenz Alessandra B.²

Affiliation:

1. J&S Studies Inc.; College Station, TX USA

2. Stiefel, a GSK company; Research Triangle Park, NC USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.7/fullpdf

Reference29 articles.

1. A newonce-daily, optimized, fixed combination of clindamycin phosphate 1.2% and low-concentration benzoyl peroxide 2.5% gel for the treatment of moderate-to-severe acne;Gold;J Clin Aesthet Dermatol.,2009

2. Benzoyl peroxide: enhancing antibiotic efficacy in acne management;Dutil;Skin Ther Lett.,2010

3. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations;Webster;J Drugs Dermatol.,2009

4. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization;Tanghetti;Dermatol Clin.,2009

5. Topical benzoyl peroxide increases the sebum excretion rate in patients with acne;Cunliffe;Br J Dermatol.,1983

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current topical treatments for acne;Klinicheskaya dermatologiya i venerologiya;2022

2. Simultaneous determination of tazarotene, clindamycin phosphate and their active metabolites in Bama mini-pig skin by LC-MS/MS: Application to the development of a tazarotene/clindamycin phosphate cream;Journal of Chromatography B;2021-01

3. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, invest;The Journal of Dermatology;2018-06-15

4. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, acti;British Journal of Dermatology;2015-01-07

5. Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris;Clinical Pharmacology in Drug Development;2014-06-09